Language： 简体中文 English

Program

大会日程

Unrelenting Innovation: The prospect and challenges in the next decade

Important Date

Sep 30th, 2021
 Closing Date for the Abstract Contribute
Sep 30th, 2021
 Closing Date for the Early-bird Registration
Nov 3 - 4th, 2021
 On-site Registration and Check-in
Nov 4th, 2021 
 Committee Meeting of Pharmacometrics Professional Committee of 

Chinese Pharmacological Society (committee members only)
Nov 5 - 6th, 2021
 The Formal Agenda of Convention and Exhibition 
Nov 7th, 2021 
 A3 pharmacometric conference (online)
Oct 25th - Nov 9th, 2021
 Workshops


Symposium Topics:
    Quantitative system pharmacology: the latest update and potential future opportunities
    Model-informed drug development and regulatory science: China and the United States innovative regulatory applications and future directions


Symposium Chapter Topics (3 Chapters, 12 topics, 36 reports)

    Innovative Drug Research and Development Chapter 

Topic 1: Model-informed drug development and applications: Challenges and cases 
Topic 2: Innovative antitumor immune drug development: Regulatory requirements, and the challenges and applications for quantitative pharmacology
Topic 3: Applications and challenges for quantitative pharmacology to accelerate clinical research and development in bispecific antibody, antibody drug conjugation and biosimilar drugs
Topic 4: The clinical development efficiency and the investigation of application strategies for modeling, simulation of Nano-particles and inhalation formulations— AI techniques 



    Quantitative Pharmacology and Interdisciplinary Chapter 

Topic 5: Model-informed clinical precision dosing: the latest update and prospect in 2030
Topic 6: Pharmacokinetics, pharmacodynamics and disease progression models: The latest research progress as well as the challenge and strategy in applications
Topic 7: The physiological based pharmacokinetics and pharmacodynamics research: the latest update and future opportunities
Topic 8: Acceleration of innovative drug development by real world data and data science: Applications and strategies of Boao China and the United States

    Quantitative Pharmacology and Interdisciplinary Chapter 

Topic 9: The research of the relationship between specific population and drug-drug interactions: Interpretation of the Chinses guidance and innovative research method 
Topic 10: Acceleration of innovative drug development for infectious disease: the application and challenges for quantitative pharmacology
Topic 11: Innovative drug development for children: the interpretations of Chinese and the United States’ guidance, and the current challenges and future opportunities
Topic 12: The strategy of development of new therapeutic drugs (cell therapy and small nucleic acid drugs) and drugs for treating rare diseases—the challenges in application and prospect for quantitative pharmacology 

 

   The Symposium Salon Topics: 

Regulatory Salon: The opportunity and challenge for quantitative pharmacology applications in the innovative drug development 
Educational Salon: The education and career development of quantitative pharmacology


The Preliminary List of International and Domestic Academic Committee（in alphabetical order by last name）:

Jeffrey S. Barrett Vice President of Critical Path Institute
Brian Corrigan Global Head, Clinical Pharmacology at Pfizer, USA
Williams J. Jusko Professor of University at Buffalo
Mats O. Karlsson Professor of Department of Pharmacy at Uppsala University
Catherijne A. J. Knibbe Professor of Division of Systems Biomedicion and Pharmacology of the LACDR at Leiden University 
Donald E. Mager Professor of University at Buffalo
Scott F. Marshall Vice President of Clinical Pharmacology, modeling and simulation at GSK Asia
Karen Thudium Mueller Vice President of Translational Science at GentiBio, USA
Cynthia J. Musante Director of Early Clinical Development at Pfzier, USA  
Daniele Ouellet Vice President of Global Head of Clinical Pharmacology and Pharmacometrics at The Janssen Pharmaceutical Companies of Johnson & Johnson
Richard Peck Director of Pharma Research and Development (pRED), Roche Innovation Centre
Amin Rostami-Hodjegan Professor of Centre for Applied Pharmacokinetic Research at University of Manchester
Joel Tarning Centre for tropical medicine at University of Oxford
Yanguang Cao Professor of Eshelman School of Pharmacy at University of North Carolina at Chapel Hill
Rui Chen Associate Researcher of Peking Union Medical College Hospital Clinical Pharmacology Research Centre  
Nengneng Cheng Professor of School of Pharmacy at Fudan University
Zeneng Cheng Professor of Xiangya School of Pharmaceutical Sciences at Central South University
Junjie Ding Director of Clinical Pharmacologist at AstraZeneca
Yalin Dong Director Pharmacy Department at First Affiliated Hospital of Xi’an Jiaotong University 
Yi Fang Director of Phase I Clinical Trial Research Laboratory of National Clinical Trial Centre at Peking University People’s Hospital
Feng Guo CEO of Genor Biopharma
Pei Hu Professor of Peking Union Medical College Hospital Clinical Pharmacology Research Centre
Qin Huang Senior Vice President of Simcere Pharmaceutical Group Limited
Ji Jiang Professor of Peking Union Medical College Hospital Clinical Pharmacology Research Centre
Min Jiang Director of GCP office at Beijing Cancer Hospital 
Zheng Jiao Director of department of Pharmacy at Shanghai Chest Hospital Shanghai Jiaotong University
Yuyan Jin Director of Pharmaceutical sciences at Roche Innovation Center
Gailing Li Senior Director of R & D Center and Director of Clinical Pharmacology at Johnson & Johnson
Haiyan Li Director of Drug Clinical Trial Center at Peking University Third Hospital
Lujin Li Associate Professor of Institute of Interdisciplinary Integrative Medicine Research
Gangxin Li Associate Professor of Department of Pharmacy at Beijing Friendship Hospital, Capital Medical University
Dongyang Liu Deputy Director of Drug Clinical Trial Center at Peking University Third Hospital
Huichen Liu Director of Clinical Trial Institution at Fuwai Hospital
Ping Liu General Manager of Beijing Linking Truth Technology Co., Ltd.
Qi Liu Associate Director for Innovation & Partnership at Office of Clinical Pharmacology, U.S. Food and Drug Administration
Xiaodong Liu Professor of School of Pharmacy China Pharmaceutical University
Xiaoxi Liu General Manager of Zcapsule Pharmaceuticals
Jianfeng Lu Chairman of Drug Research Institution at Aosaikang Pharm
Guangli Ma Head of Clinical pharmacology at Overland Pharmaceuticals
Peimin Ma Director of China R & D Science Department at AstraZeneca
Jing Nie Director of Clinical Pharmacology at Zai Lab
Defang Ouyang Professor of Institute of Chinese Medical Sciences at University of Macao
Jun Shi Senior Vice President of Early Development & Clinical Pharmacology at dMed
Haifeng Song* Researcher of Bio-omics Institute at Academy of Military Medical Sciences of the PLA Academy of Military Medical Sciences
Duxin Sun Dean of College of Pharmacy at University of Michigan
Zhenbo Tong Professor of School of Energy and Environment at Southeast University
Bing Wang Co-founder/CEO of Amador Bioscience Ltd.
Jian Wang* Co-founder/CEO of Amador Bioscience Ltd.
*Pending confirmation Associate Director of Office of New Drugs (OND), Office of Specialty Medicine at U.S. Food & Drug Administration (FDA)
Yaning Wang Former Director of Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research (CDER) at U.S. Food & Drug Administration (FDA)
Minji Wei Director of Pharmacokinetics Laboratory at Institute of Clinical Pharmacology, Peking University
Xiaoqiang Xiang Associate Researcher, School of Pharmacy at Fudan University
HaitangXie Director of Anhui Provincial Center for Drug Clinical Evaluation
Guoping Yang Director of Center for Clinical Trials of The Third Xiangya Hospital of Central South University
Jiansong Yang Mosim Ltd.
Jin Yang Professor of Department of Pharmaceutics at China Pharmaceutical University 
Jun Yang Founder of Quantify Bio-Center, USA（Former senior reviewer of FDA, USA）
Shoujun Yuan Institute of Radiation Medicine at Academy of Military Medical Sciences
Jing Zhang Deputy Director of Institute of Antibiotic at Huashan Hospital Fudan University
Libo Zhao Professor of Peking University Third Hospital
Liang Zhao Director of Division of Quantitative Methods and Modeling, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER) at U.S. Food & Drug Administration (FDA)
Ping Zhao Senior Program Officer at Bill & Melinda Gates Foundation
Wei Zhao Director of Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University
Sylvia Zhao Executive Director of China Development Unit Head Cardiovascular, Renal & Metabolic Disease at Novartis
Qingshang Zheng Professor of Institute of Interdisciplinary Integrative Medicine Research
Jiawei Zhou PhD candidate of Eshelman School of Pharmacy at University of North Carolina at Chapel Hill
Tianyan Zhou Professor of Peking University School of Pharmaceutical Sciences
Xiao Zhu Associate Professor of School of Pharmacy, Fudan University
Xiaocong Zuo Professor of Xiangya School of Pharmaceutical Sciences at Central South University
*Pending confirmation



A3 pharmacometric conference：




  • Reports from China, Japan and Korea
  • Research cooperation closed-door meeting of innovative drug development and quantitative pharmacology for China, Japan and Korea 







































































Workshops:

Date

Workshop

Featured speaker

Oct 25-29th 2021 Morning

Advanced PKPD workshop (online)

William J. Jusko & Donald E. Mager (University at Buffalo – SUNY)

Nov 3rd 2021 Morning

Model-informed innovative antitumor drug development (online)

Pfizer U.S.

Nov 4th 2021

Model-informed biotechnology drugs development

Peimin Ma, Bing Wang, Xiaoyu Yan

Nov 8-12th 2021 Afternoon

Advanced methods for population model building, evaluation and usage in NONMEM (online)

Mats O. Karlsson，Andrew Hooker

(Uppsala University)

Nov 9th 2021 Morning

Challenges in development of Gene and cell therapies and application progresses of clinical and quantitative pharmacology (online)

The International Consortium for Innovative and Quality in Pharmaceutical Development


Note: Please check the Symposium website for more registration information. In addition, a PKSIM training program is pending confirmation.


More

Congress has ended

Fold

Congress has ended

View on Mobile Devices

Conference Admin